GTC Anticipates Reaching U.S. Market In 2009 With Human Antithrombin ATryn
This article was originally published in The Pink Sheet Daily
Executive Summary
Company tells “The Pink Sheet” DAILY it will seek indications for larger patient populations than initial target of hereditary antithrombin deficiency.